Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00942825 · COMPLETED

Trial details

NCT number: NCT00942825
Sponsor: CanBas Co. Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non-squamous Non Small Cell Lung Cancer

Start date: 2009-04-01
Primary completion: 2013-07-01
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.